Variant report
Variant | nsv519488 |
---|---|
Chromosome Location | chr18:11562631-11565370 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs535529 | chr18:11562631-11562632 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs550801665 | chr18:11562678-11562679 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs566721240 | chr18:11562683-11562684 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs534073471 | chr18:11562694-11562695 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs553430099 | chr18:11562757-11562758 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs568447948 | chr18:11562799-11562800 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs535966316 | chr18:11562846-11562847 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs184033293 | chr18:11562853-11562854 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs62084068 | chr18:11562857-11562858 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs565407165 | chr18:11562885-11562886 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs554532 | chr18:11562954-11562955 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs367686166 | chr18:11562959-11562960 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs75481793 | chr18:11562980-11562981 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs548447734 | chr18:11563023-11563024 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs540503745 | chr18:11563033-11563034 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs190948679 | chr18:11563057-11563058 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs573267721 | chr18:11563067-11563068 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs543925640 | chr18:11563075-11563076 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs559112922 | chr18:11563090-11563091 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs117215922 | chr18:11563123-11563124 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs566805303 | chr18:11563146-11563147 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs117818197 | chr18:11563167-11563168 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs370562102 | chr18:11563168-11563169 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs369340277 | chr18:11563193-11563194 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs182531168 | chr18:11563222-11563223 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs534258761 | chr18:11563269-11563270 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs560088376 | chr18:11563278-11563279 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs527617036 | chr18:11563299-11563300 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs144939924 | chr18:11563300-11563301 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs568485465 | chr18:11563340-11563341 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs535800930 | chr18:11563362-11563363 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs187186113 | chr18:11563373-11563374 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs377209594 | chr18:11563397-11563398 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs544952234 | chr18:11563398-11563399 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs569373765 | chr18:11563430-11563431 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs192054948 | chr18:11563445-11563446 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs528657665 | chr18:11563463-11563464 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs77073813 | chr18:11563468-11563469 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs183095276 | chr18:11563470-11563471 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs573086776 | chr18:11563491-11563492 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs146789412 | chr18:11563527-11563528 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs187638807 | chr18:11563534-11563535 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs193233631 | chr18:11563556-11563557 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs530399013 | chr18:11563576-11563577 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs148997634 | chr18:11563681-11563682 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs544156592 | chr18:11563700-11563701 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs143828944 | chr18:11563775-11563776 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs577716747 | chr18:11563836-11563837 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs185733023 | chr18:11563935-11563936 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs560308333 | chr18:11563975-11563976 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intellectual disability | 22102821 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Seminomas | 18059402 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Cancer | 21183584 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Melanoma | 18172304 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Colorectal cancer | 19150955 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Trisomy 18 syndrome | 17576883 | CNVD |
Autism | 20808228 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Multiple myeloma | 17550852 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
abnormal development | 18461090 | CNVD |
Heart disease | 21282601 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Acute myeloid leukemia | 17377590 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Developmental delay | 21147756 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16620391 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Glioma | 17123091 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr18:11552400-11572000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr18:11560000-11562800 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
3 | chr18:11562200-11565200 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
4 | chr18:11562800-11565800 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
5 | chr18:11565200-11566400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |